United States · FDA National Drug Code directory
Mycapssa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-550_84ca5e5f-886b-4216-b748-f7dad1201db0
- Product NDC
- 10122-550
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Octreotide
- Labeler
- Chiesi USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200706
- Source listing expiry
- 20261231
Source-listed ingredients
- OCTREOTIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 DOSE PACK (10122-550-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 10122-550-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →